152 related articles for article (PubMed ID: 29140706)
21. Ursodeoxycholic acid improves ethinyl estradiol-induced cholestasis in the rat.
Jacquemin E; Dumont M; Mallet A; Erlinger S
Eur J Clin Invest; 1993 Dec; 23(12):794-802. PubMed ID: 8143756
[TBL] [Abstract][Full Text] [Related]
22. Protective effect of heme oxygenase induction in ethinylestradiol-induced cholestasis.
Muchova L; Vanova K; Suk J; Micuda S; Dolezelova E; Fuksa L; Cerny D; Farghali H; Zelenkova M; Lenicek M; Wong RJ; Vreman HJ; Vitek L
J Cell Mol Med; 2015 May; 19(5):924-33. PubMed ID: 25683492
[TBL] [Abstract][Full Text] [Related]
23. [Ursodeoxycholic acid in the treatment of cholestatic liver diseases].
Arrese M; Accatino L
Rev Med Chil; 1993 Apr; 121(4):439-46. PubMed ID: 8272619
[TBL] [Abstract][Full Text] [Related]
24. Induction of hepatic multidrug resistance-associated protein 3 by ethynylestradiol is independent of cholestasis and mediated by estrogen receptor.
Ruiz ML; Rigalli JP; Arias A; Villanueva S; Banchio C; Vore M; Mottino AD; Catania VA
Drug Metab Dispos; 2013 Feb; 41(2):275-80. PubMed ID: 23077105
[TBL] [Abstract][Full Text] [Related]
25. Ursodeoxycholic acid loaded dual-modified graphene oxide nanocomposite alleviates cholestatic liver injury through inhibiting hepatocyte apoptosis.
Zhou W; Yang X; Yin Y; Chen S; Yang L; Li T; Liu J; Lu B; Yang Z; Li R; Zhang M
Colloids Surf B Biointerfaces; 2024 Jun; 238():113904. PubMed ID: 38603845
[TBL] [Abstract][Full Text] [Related]
26. Ursodeoxycholic acid limits liver histologic alterations and portal hypertension induced by bile duct ligation in the rat.
Poo JL; Feldmann G; Erlinger S; Braillon A; Gaudin C; Dumont M; Lebrec D
Gastroenterology; 1992 May; 102(5):1752-9. PubMed ID: 1568585
[TBL] [Abstract][Full Text] [Related]
27. Hepatic gene transfer of human aquaporin-1 improves bile salt secretory failure in rats with estrogen-induced cholestasis.
Marrone J; Soria LR; Danielli M; Lehmann GL; Larocca MC; Marinelli RA
Hepatology; 2016 Aug; 64(2):535-48. PubMed ID: 26999313
[TBL] [Abstract][Full Text] [Related]
28. Effect of ursodeoxycholic acid administration on bile duct proliferation and cholestasis in bile duct ligated rat.
Frezza EE; Gerunda GE; Plebani M; Galligioni A; Giacomini A; Neri D; Faccioli AM; Tiribelli C
Dig Dis Sci; 1993 Jul; 38(7):1291-6. PubMed ID: 8325189
[TBL] [Abstract][Full Text] [Related]
29. Kinsenoside Alleviates 17α-Ethinylestradiol-Induced Cholestatic Liver Injury in Rats by Inhibiting Inflammatory Responses and Regulating FXR-Mediated Bile Acid Homeostasis.
Ming J; Xu Q; Gao L; Deng Y; Yin J; Zhou Q; Tong Q; Zhang Y
Pharmaceuticals (Basel); 2021 May; 14(5):. PubMed ID: 34064649
[TBL] [Abstract][Full Text] [Related]
30. Ursodeoxycholic acid and 18β-glycyrrhetinic acid alleviate ethinylestradiol-induced cholestasis via downregulating RORγt and CXCR3 signaling pathway in iNKT cells.
Li X; Liang X; Gu X; Zou M; Cao W; Liu C; Wang X
Toxicol In Vitro; 2024 Apr; 96():105782. PubMed ID: 38244730
[TBL] [Abstract][Full Text] [Related]
31. Ursodeoxycholic acid (UDCA) in the treatment of chronic cholestatic diseases.
Calmus Y; Poupon R
Biochimie; 1991 Oct; 73(10):1335-8. PubMed ID: 1782227
[TBL] [Abstract][Full Text] [Related]
32. Oxidative stress and apoptosis in fetal rat liver induced by maternal cholestasis. Protective effect of ursodeoxycholic acid.
Perez MJ; Macias RI; Duran C; Monte MJ; Gonzalez-Buitrago JM; Marin JJ
J Hepatol; 2005 Aug; 43(2):324-32. PubMed ID: 15970352
[TBL] [Abstract][Full Text] [Related]
33. Glyceric Prodrug of Ursodeoxycholic Acid (UDCA): Novozym 435-Catalyzed Synthesis of UDCA-Monoglyceride.
Zappaterra F; Costa S; Summa D; Semeraro B; Cristofori V; Trapella C; Tamburini E
Molecules; 2021 Oct; 26(19):. PubMed ID: 34641510
[TBL] [Abstract][Full Text] [Related]
34. Is ursodeoxycholic acid detrimental in obstructive cholestasis? A propos of a case of malignant biliary obstruction.
Bessone F; Roma MG
Ann Hepatol; 2016; 15(3):442-7. PubMed ID: 27049500
[TBL] [Abstract][Full Text] [Related]
35. Ca2+-dependent cytoprotective effects of ursodeoxycholic and tauroursodeoxycholic acid on the biliary epithelium in a rat model of cholestasis and loss of bile ducts.
Marzioni M; Francis H; Benedetti A; Ueno Y; Fava G; Venter J; Reichenbach R; Mancino MG; Summers R; Alpini G; Glaser S
Am J Pathol; 2006 Feb; 168(2):398-409. PubMed ID: 16436655
[TBL] [Abstract][Full Text] [Related]
36. Investigations of the total flavonoids extracted from flowers of Abelmoschus manihot (L.) Medic against α-naphthylisothiocyanate-induced cholestatic liver injury in rats.
Yan JY; Ai G; Zhang XJ; Xu HJ; Huang ZM
J Ethnopharmacol; 2015 Aug; 172():202-13. PubMed ID: 26133062
[TBL] [Abstract][Full Text] [Related]
37. Impaired activity of the bile canalicular organic anion transporter (Mrp2/cmoat) is not the main cause of ethinylestradiol-induced cholestasis in the rat.
Koopen NR; Wolters H; Havinga R; Vonk RJ; Jansen PL; Müller M; Kuipers F
Hepatology; 1998 Feb; 27(2):537-45. PubMed ID: 9462655
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and evaluation of water-soluble prodrugs of ursodeoxycholic acid (UDCA), an anti-apoptotic bile acid.
Dosa PI; Ward T; Castro RE; Rodrigues CM; Steer CJ
ChemMedChem; 2013 Jun; 8(6):1002-11. PubMed ID: 23640741
[TBL] [Abstract][Full Text] [Related]
39. Different effects of ursodeoxycholic acid on intrahepatic cholestasis in acute and recovery stages induced by alpha-naphthylisothiocyanate in mice.
Zhang L; Su H; Li Y; Fan Y; Wang Q; Jiang J; Hu Y; Chen G; Tan B; Qiu F
Toxicol Appl Pharmacol; 2018 Mar; 342():69-78. PubMed ID: 29407775
[TBL] [Abstract][Full Text] [Related]
40. Effects of ursodeoxycholic acid on hemodynamic and renal function abnormalities induced by obstructive jaundice in rats.
Poo JL; Estanes A; Pedraza-Chaverrí J; Cruz C; Uribe M
Ren Fail; 1995 Jan; 17(1):13-20. PubMed ID: 7770639
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]